Form 4 for MRNA Moderna
Accepted 2022-05-02 00:00:00 ET · period of report 2022-04-28 · accession 0001127602-22-012852 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-02 | 2022-04-28 | MRNA | NABEL ELIZABETH G | Dir | M - OptEx | $0.00 | +703 | 703 | New | $0 |
| DM | 2022-05-02 | 2022-04-28 | MRNA | NABEL ELIZABETH G | Dir | A - Grant | $0.00 | +4,731 | 670 | New | $0 |
| D | 2022-05-02 | 2022-04-28 | MRNA | NABEL ELIZABETH G | Dir | M - OptEx | $0.00 | -703 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-28 | M | A | 703 | $0.00 | 703 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-04-28 | A | A | 4,061 | $0.00 | 4,061 | D | $142.52 · — to — | 4,061 Common Stock | (F3) This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |
| 3 | Derivative | Restricted Stock Units | 2022-04-28 | A | A | 670 | $0.00 | 670 | D | $0.00 · — to — | 670 Common Stock | (F4) The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. |
| 4 | Derivative | Restricted Stock Units | 2022-04-28 | M | D | 703 | $0.00 | 0 | D | $0.00 · — to — | 703 Common Stock | (F2) The shares subject to this restricted stock unit award vested in full on April 28, 2022. |